And a happy turkey day to you as well, and to all others who contribute to this board.
Of course, I am looking ahead to Xmas, by which time Santa Howard should have deliveed the 102 OC extension data. I predict the data will be good enough to receive AA consideration from the FDA based on listening to the R&D day presentation again a few nights ago. Interesting times ahead.
The tanking of NKTR in response to the SLXP discussions may have been an early X-Mas present. I was able to grab a couple thousand more shares just around 6. If 102 comes through in addition to the Naloxegol panic being indeed an overreaction, and BAX moving ahead with revelation of good PI/II data we may all need neckbraces to deal with price whiplash.
Thanks, having a week from hell (nothing to do with NKTR, but stuff that actually matters). In case people missed it the MAPP resubmission has been accepted. Not huge news for NKTR, but certainly a modest positive.